Institutional Capital & Cannabis Europe
London, UK
June 26, 2019

Description

IMN is excited to announce a new partnership with Prohibition Partners, Europe’s leading provider of market and strategic insights into the European legal cannabis markets. IMN and Prohibition Partners will co-host the first annual Institutional Capital & Cannabis Conference Europe (IC3 Europe), June 26, in London. 

With over double the population of the US and Canada combined, Europe is expected to become the largest legal cannabis market in the world, within the next five to ten years. Some analysts are estimating that the European legal cannabis market will be worth €125 billion by 2028. The multijurisdictional nature of Europe makes it a complex market but lessons can be learned from regulated markets as industry players look to take advantage of the opportunities that exist.

IMN’s IC3 forums are a meeting place for investors who wish to invest or learn more about this exciting and high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business. 

Our US conferences have earned a reputation for quality content, expert speakers, and a high representation of institutional investors. Previous IC3 participants include leading cannabis brands Canndescent, MedMen, MedReleaf, Flow Kana, Tikun Olam and funds such as Privateer Holdings (Tilray, Marley Natural), Casa Verde (Eaze), Gotham Green Partners (Cronos), Merida Capital (KushCo) and a number of ex-Wall Street professionals turned private investors. 

IMN is excited to bring this one-of-kind forum aimed at sophisticated investors seeking alternative asset classes and portfolio diversification to the UK this June.

Conference Highlights

Networking Tutorial

    Platform Introduction

    LOADING MEDIA...

    Getting Started

    LOADING MEDIA...

    Updating Personal Info

    LOADING MEDIA...

    Updating Demographics

    LOADING MEDIA...

    Searching By Name/Company

    LOADING MEDIA...

    Filter By Demographics

    LOADING MEDIA...

    Send Invitation

    LOADING MEDIA...

    Accept Invitation

    LOADING MEDIA...

    Messaging Connections

    LOADING MEDIA...

    Post Conference Content

    LOADING MEDIA...

My Agenda

  • To view your agenda you must be signed in Sign-In

Agenda

    Wednesday, June 26th, 2019

      7:45 AM
      Breakfast & Registration


      8:45 AM
      Global State of the Industry and Market Outlook

      • It’s 2019 and the global cannabis industry is undergoing a rapid evolution.  Last year saw the legalisation of recreational cannabis use in Canada, significant progress made at the state level in the US, and the introduction of legislation in a number of European nations.  This session will look at the numbers, highlighting the most promising growth markets in Europe and abroad.
        • Vivien Azer , Managing Director (Cowen and Company)

      9:15 AM
      Investment Opportunities in Legal Cannabis

      • Over $10billion was invested in the North American legal cannabis market in 2018.  There are a number of investment sectors in the cannabis industry that attract attention from various capital vehicles.  Each sector is different from the other and has unique opportunities and challenges associated with it.  This opening panel will discuss how opportunities are evolving across these sectors and what investors should consider when making decisions. 
        • Narbe Alexandrian , President (Canopy Rivers)
        • Karan Wadhera , Managing Partner (Casa Verde Capital)
        • Paul Henderson , CEO (Grupo Flor)
        • Tahira Rehmatullah , Managing Director (Hypur Ventures)

      10:00 AM
      Update on the Regulatory Landscape in Europe

      • Significant legislative events in Europe were witnessed by the sector last year.  The UK legalized the limited prescribed use of medical cannabis products and Germany has issued more tenders for domestic medical cannabis production.  Despite this, considerable issues with access remain. This unique panel will examine the legislative and regulatory status of medical and recreational cannabis across Europe, how these laws and regulations are being implemented, and what the major stumbling blocks are when setting up such frameworks. 
        • Alfredo Pascual , International Analyst (Marijuana Business Daily)
        • Molly Meacher , Chairman (APPG for Drug Policy Reform)
        • Prof. Mike Barnes , Chief Medical Officer (European Cannabis Holdings)
        • Ana Afuera , ENCOD Executive Committee (European Coalition for Just and Effective Drug Policies)
        • Marco Perduca , Co-Founder/ Co-ordinator (Science for Democracy/Associazione Luca Coscioni)

      10:45 AM
      Networking Break


      11:15 AM
      The Path to Public Markets

      • We take a look at the journeys of public companies in North America as they discuss their success stories, setbacks they overcame and pitfalls to be avoided.
        • Nick Davis , Chief Executive (Memery Crystal)
        • Alex Brooks , Senior Analyst (Canaccord Genuity)
        • Navdeep Dhaliwal , CEO (Supreme Cannabis)

      12:00 PM
      Assessing the Upside of Investing in Europe

      • Europe is on track to become the world’s largest legal cannabis market within the next five years, with over €500million of investments into European cannabis companies in the last year and a forecasted market worth of up to €123billion by 2028.  A well-regulated cannabis industry could bring significant benefits and opportunities to European economies.  What do developments in North America and other markets mean for Europe?
        • Will Muecke , Managing Member (Artemis Growth Partners)
        • Steve Malloy , CEO (PharmaRolly Holdings BV)
        • Kris Krane , President & Co-Founder 4Front (Cannex Capital)

      12:45 PM
      Lunch


      1:45 PM
      Impact Investing: Medical Efficacy and Societal Impact of Legal Cannabis

      • More and more investors are looking to have an impact investing allocation in their portfolio.  Social justice, regulatory reform and improving the overall health of our society make cannabis a prime fit for this allocation.  This panel will address the socioeconomic benefits that a well-regulated cannabis industry can offer.
        • Aras Azadian , CEO, Chairman, and Co-Founder (Avicanna)
        • Hannah Simon , Managing Director (The Medical Cannabis Clinics )

      2:25 PM
      Strategic Approaches to Building a Successful Cannabis Business

      • There are many different approaches to building a business but in the growing cannabis space, there are certain things that every business and investor needs to know.  This session will address the importance of intellectual property (IP) and protection strategies, along with scaling and the major differences between businesses “touching the plant” and “not touching the plant”.
        • Joel Sherlock , Chairman & Co-Founder (Vitalis Extraction Technology)

      3:05 PM
      Due Diligence Best Practice for Cannabis Investments

      • For many investors, this is their first time deploying capital into the space. As such their teams need to understand this unique investment opportunity. This panel of analysts and investors specialize in the cannabis sector and will discuss their processes and best practices.  
        • James Glenister , Business Development (Alinga Capital LLC)
        • Jennifer Sanders , Founder & CEO (CNS Equity Partners)
        • Emily Paxhia , Managing Director (Poseidon)

      3:45 PM
      Networking Break


      4:00 PM
      From Theory to Reality: Invest Like the Best

      • Following a day of education and discussion, this session pulls it all together, and we hear from experienced investors and finance professionals who are already active in this exciting new asset class. Our panelists reveal firsthand accounts of where they've found success, hard lessons learned and pitfalls to be avoided, and key nuggets of advice they have for those considering investing in this space.
        • Nic Easley , CEO & Managing Director (Multiverse Capital)
        • Thomas Mazarakis , Portfolio Advisor (Salveo Capital)

      4:40 PM
      Crystal Balling the Future of Cannabis in Europe

      • After a full, solid day of discussion, where does this leave us?  What has surprised us in the past year and what can we expect for the months and years ahead?  Industry leaders from business and policy discuss legalisation, regulation and what this means for all of you.
        • Stephen Murphy , Co-Founder & Group Managing Director (ECH)
        • Rob Kampia , Executive Director (Marijuana Leadership Campaign)
        • Drake Sutton-Shearer , CEO (PRØHBTD Media)
        • Troy Dayton , CEO (The Arcview Group)
        • Crispin Blunt , Reigate Constituency (UK Parliament )

      5:20 PM
      Keynote Session


      5:40 PM
      Cocktail Reception


      6:40 PM
      The Inaugural Institutional Capital & Cannabis Conference (Europe) Concludes


Sponsors

Register

To register for this conference you must be signed in

  • Investor Early Bird * - £395
  • Investor - £595
  • Standard Early Bird - £995
  • Standard rate - £1,295
  • On-site rate - £1,495
Sign-In

Prohibition Partners

Contact Us

Venue

  • Conference Venue
  • etc.venues, Liverpool Street - 155 Bishopsgate


    Liverpool Street - 155 Bishopsgate
    London, England, EC2M 3YD
    UK

Speakers


1120 Avenue of the Americas, 6th Floor, New York, NY 10036
Tel: +1(212)901-0506 Fax: +1(212)768-2484
Email: mail@imn.org


View Full Site
You need to login before accessing this section. Click "Login" from bottom menu.

Please sign in

Create Account Recover Password Sign in with LinkedIn

Enter Your Email: